Skip to main content
Clinical Trials/DRKS00014582
DRKS00014582Active, not recruiting未知

Prospective, multicenter, comparative study of recurrence-free survival after liver transplantation in two tumor stage-defined groups (UNOS T2 versus Milan-out / UCSF-in) of patients with hepatocellular carcinoma (HCC) in cirrhosis and locoregional therapy for bridging the waiting period - TOM

niversitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel0 sites14 target enrollmentStarted: February 12, 2020Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Active, not recruiting
Sponsor
Enrollment
14

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Non-randomized controlled study
Masking
Open (masking not used)

Eligibility Criteria

Ages
18 Years to one (—)
Sex
All

Inclusion Criteria

  • •Patients with HCC in cirrhosis according to current guidelines
  • •- Patients with HCC in cirrhosis in the tumor stage UNOS T2 or patients with HCC in cirrhosis outside Milan and within the UCSF criteria
  • •- Age from 18 years
  • •- Decision of the transplant conference with approval for liver transplantation
  • •- Decision of the tumor conference with diagnosis and tumor stage
  • •- Listing at Eurotransplant

Exclusion Criteria

  • •- Patients with extrahepatic HCC manifestation (N + M +)
  • •- patients with macrovascular invasion of HCC (V2)
  • •- Existing pregnancy

Investigators

Sponsor
niversitätsklinikum Schleswig-Holstein (UKSH), Campus Kiel

Similar Trials

Prospective, multicenter, comparative... | Clinical Trial